LEP and colorectal cancer: In a colorectal cancer cohort of 1003 cases and 1303 matched controls, LEPR rs6588147, rs1137101, and LEP rs2167270 polymorphisms were found to be associated with a decrease in cancer risk, whereas LEPR rs1137100 was associated with cancer susceptibility [34].